Focusing on higher-risk groups dropped the pool who qualified for imaging down from 53% to 38%, according to new research published in Cancer Reports.

The pair will combine machine learning with digitized slide data to enhance diagnoses, initially focusing on prostate, breast, colorectal and lung cancers.

Patients who received a novel amino acid-based radiopharmaceutical showed better cancer control rates compared to those whose treatment was guided by bone scans, CT, or MRI alone.

The Laurel, Maryland, radiology provider had its accreditation stripped in March and has yet to notify patients who may have been affected, according to the FDA.

Ink put into the skin can migrate to other areas of the body over time and, in some patients, mimic lymph node calcifications on mammograms.

The health insurer reversed its coverage denial for imaging of gastric and esophageal oncologic indications, while other restrictions remain in place. 

Consistent metrics would limit frustrating back-and-forths between rads and providers while also significantly enhancing patient care.

Nearly 4% of individuals with renal cell carcinoma showed asymptomatic spread to the brain, oncologists reported in the April issue of JNCCN.